Le Lézard
Classified in: Science and technology, Sports and recreation
Subject: PDT

Beyond Protocol Launches Unhackable Blockchain-Ledger Technology to Record Proof of Ownership of Rare Collectibles


CHICAGO, July 30, 2021 /PRNewswire/ -- Beyond Protocol, a new blockchain project currently operating in stealth mode with plans to launch this fall, announced the first-ever application of their cutting edge blockchain-ledger technology within the field of rare collectibles. Through a partnership with BRKRZ and Beckett Collectibles, LLC, ("Beckett") select winners of valuable sneakers and ultra-rare trading cards at tonight's National Sports Collectors Convention will be able to have their wins recorded securely on the blockchain, and probabilistically unable to be modified, through Beyond Protocol's blockchain-ledger technology. 

To launch this technology, Beckett and BRKRZ are set to host a live box-break event at tonight's National Sports Collectors Convention, where former Miss Global USA and Beyond Protocol Spokeswoman Maurah Ruiz will unveil two valuable pairs of sneakers owned by acclaimed UFC fighter Jorge Masvidal, who holds the record for the fastest knockout in the Octagon. Two winners of these sneakers will have their wins recorded securely on the blockchain through Beyond Protocol's blockchain-ledger technology, rendering these recordings probabilistically impossible to be hacked or modified. 

After the sneaker event, Beckett will grade ultra-rare trading cards as part of a separate box break with Masvidal and the winners of those valuable cards will have their wins recorded through Beyond Protocol's technology. The MMA star has multiple parallel and autograph cards in the highly collectible set.

"Our team is thrilled to unveil our first-ever use case of our groundbreaking technology, especially in the exciting world of rare collectibles," said Jonathan Manzi, CEO and co-founder of Beyond Protocol. "With nearly limitless possible uses of our code, this is the first of many industries we plan to bring an unseen level of security and transparency through our blockchain technology." 

To learn more about the unique technology behind this event, check out Manzi's latest explainer video here.

About Beyond Protocol:
Beyond Protocol is a distributed ledger technology project that offers a secure and probabilistically un-hackable solution to inter-device/Internet of Things (IoT) communication. With one line of code, Beyond Protocol's platform enables secure message brokering between devices through the utilization of blockchain technology and unique hardware signatures, and equips devices with a cryptocurrency-based payment gateway for automated, behind-the-scenes transactions. Beyond Protocol seeks to build real, practical solutions for device security and payments within an economy of machines. 

PRESS CONTACT:
[email protected] 

SOURCE Beyond Protocol


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: